Frances Platt, University of Oxford (UK)
Frances Platt moved to the Biochemistry Department of the Oxford University.
Frances Platt joined the Scientific and Medical Committee of Telethon in 2015.
In 1982, Frances Platt graduated in Zoology at Imperial College, London. She then obtained a research doctorate in Animal Physiology at the University of Bath in 1985. Between 1986 and 1987 she held a post-doc at Washington University Medical School in St Louis (USA). Frances Platt moved then to the Biochemistry Department of the Oxford University, where she studied how an anomalous accumulation of glycosphingolipids may cause diseases linked to lysosomial storage. From 1996 to 2002, she conducted research with the aid of a study grant from the Lister Institute. In 2006, she moved to the Department of Pharmacology of the Oxford University. In 2011, she was elected as a member of the Academy of Medical Sciences. Frances Platt currently researches the cell biology and pathobiology of glycosphingolipids and the development of new therapeutic treatments of disorders caused by defective glycolipids metabolism, such as Gaucher’s , Fabry, Tay-Sachs, and Sandhoff diseases and GM1 gangliosidoses, as well as type C Niemann-Pick disease. She also took part in pre-clinical development of the pharmaceutical product, Miglustat, which received worldwide approval for treatment of Gaucher’s disease (type 1) and, now, also for treatment of Niemann-Pick disease (type C).